Cargando…

Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study

OBJECTIVES: Current irritable bowel syndrome (IBS) treatments have limited efficacy and probiotics like Bacillus clausii (B. clausii) were found to be effective in the management of several gastrointestinal disorders. This phase III trial assessed the efficacy and safety of adding B. clausii (four s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Frias, Rodrigo, Consuelo-Sánchez, Alejandra, Acosta-Rodríguez-Bueno, Carlos Patricio, Blanco-Montero, Andrés, Robles, Daniel Casas, Cohen, Vanessa, Márquez, Daniel, Perez, Marcos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666949/ https://www.ncbi.nlm.nih.gov/pubmed/36380186 http://dx.doi.org/10.1007/s40272-022-00536-9

Ejemplares similares

Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review
por: Acosta-Rodríguez-Bueno, Carlos Patricio, et al.
Publicado: (2022)

Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains
por: Lippolis, Rosa, et al.
Publicado: (2013)

Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic
por: Lakshmi, Suvarna G., et al.
Publicado: (2017)

Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection
por: Paparo, Lorella, et al.
Publicado: (2020)

Immunomodulatory and Antioxidant Properties of a Novel Potential Probiotic Bacillus clausii CSI08
por: Khokhlova, Ekaterina, et al.
Publicado: (2023)

Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina(®), and insights into its probiotic properties
por: Khatri, Indu, et al.
Publicado: (2019)

Draft Genome Sequence of Bacillus clausii UBBC07, a Spore-Forming Probiotic Strain
por: Upadrasta, Aditya, et al.
Publicado: (2016)

A tale of caution: prolonged Bacillus clausii bacteraemia after probiotic use in an immunocompetent child
por: Khatri, Akshay M., et al.
Publicado: (2021)

Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores
por: Kharwar, Akash, et al.
Publicado: (2022)

The respiratory chains of four strains of the alkaliphilic Bacillus clausii
por: Abbrescia, A., et al.
Publicado: (2014)

Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation
por: Abbrescia, A., et al.
Publicado: (2014)

Current Progress and Future Perspectives on the Use of Bacillus clausii
por: Ghelardi, Emilia, et al.
Publicado: (2022)

Recommendations for the adjuvant use of the poly-antibiotic–resistant probiotic Bacillus clausii (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts
por: De Castro, Jo-Anne, et al.
Publicado: (2020)

Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report
por: García, Juan Pablo, et al.
Publicado: (2021)

Evaluation of Two Active System Encapsulant Matrices with Quercetin and Bacillus clausii for Functional Foods
por: Enciso-Huerta, Hector Alfonso, et al.
Publicado: (2022)

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
por: Lyra, Anna, et al.
Publicado: (2016)

Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis
por: Altcheh, Jaime, et al.
Publicado: (2022)

Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study
por: Marseglia, Gian Luigi, et al.
Publicado: (2007)

Synthesis of silver nanoparticles by Bacillus clausii and computational profiling of nitrate reductase enzyme involved in production
por: Mukherjee, Koel, et al.
Publicado: (2018)

Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults
por: Madempudi, Ratna Sudha, et al.
Publicado: (2019)

Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized Controlled Trial
por: Amirimani, Behnaz, et al.
Publicado: (2013)

Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India
por: Lahiri, Keya Rani, et al.
Publicado: (2022)

Characterization of an Alkali- and Halide-Resistant Laccase Expressed in E. coli: CotA from Bacillus clausii
por: Brander, Søren, et al.
Publicado: (2014)

When good bacteria behave badly: a case report of Bacillus clausii sepsis in an immunocompetant adult
por: Princess, Isabella, et al.
Publicado: (2020)

Blends of Carbohydrate Polymers for the Co-Microencapsulation of Bacillus clausii and Quercetin as Active Ingredients of a Functional Food
por: Saavedra-Leos, María Z., et al.
Publicado: (2022)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial
por: Maity, Chiranjit, et al.
Publicado: (2021)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Multiple Modular Engineering of Bacillus Amyloliquefaciens Cell Factories for Enhanced Production of Alkaline Proteases From B. Clausii
por: Zhang, Jinfang, et al.
Publicado: (2022)

Synthesis of α-hydroxy ketones and vicinal (R,R)-diols by Bacillus clausii DSM 8716(T) butanediol dehydrogenase
por: Muschallik, Lukas, et al.
Publicado: (2020)

Characterization and high-efficiency secreted expression in Bacillus subtilis of a thermo-alkaline β-mannanase from an alkaliphilic Bacillus clausii strain S10
por: Zhou, Cheng, et al.
Publicado: (2018)

Effect of Physical and Chemical Treatments on Viability, Sub-Lethal Injury, and Release of Cellular Components from Bacillus clausii and Bacillus coagulans Spores and Cells
por: Bevilacqua, Antonio, et al.
Publicado: (2020)

Draft Genome Sequence of Bacillus clausii AKU0647, a Strain That Produces Endo-β-N-Acetylglucosaminidase A
por: Higuchi, Yujiro, et al.
Publicado: (2016)

Genome sequences of 11 Alkalihalobacillus clausii, Bacillus safensis, and Escherichia coli bacteriophages isolated from bovine rumen and vagina
por: Magossi, Gabriela, et al.
Publicado: (2023)

Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis
por: Xu, Hua-Lan, et al.
Publicado: (2021)

Probiotics (Bacillus clausii and Lactobacillus fermentum NMCC-14) Ameliorate Stress Behavior in Mice by Increasing Monoamine Levels and mRNA Expression of Dopamine Receptors (D(1) and D(2)) and Synaptophysin
por: Rehman, Mujeeb Ur, et al.
Publicado: (2022)

Survival and Germination of Bacillus clausii UBBC07 Spores in in vitro Human Gastrointestinal Tract Simulation Model and Evaluation of Clausin Production
por: Ahire, Jayesh J., et al.
Publicado: (2020)

Potential application of the probiotic Bacillus licheniformis as an adjuvant in the treatment of diseases in humans and animals: A systematic review
por: Ramirez-Olea, Hugo, et al.
Publicado: (2022)

Irritable Bowel Syndrome, Gut Microbiota and Probiotics
por: Lee, Beom Jae, et al.
Publicado: (2011)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ngmm8c2jh14ko5s5pdmg6lhdu5